Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Bluebird bio Inc (NASDAQ: BLUE) closed at $0.42 in the last session, down -6.93% from day before closing price of $0.45. In other words, the price has decreased by -$6.93 from its previous closing price. On the day, 5.77 million shares were traded. BLUE stock price reached its highest trading level at $0.45 during the session, while it also had its lowest trading level at $0.4101.
Ratios:
We take a closer look at BLUE’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 0.33 and its Current Ratio is at 0.51.
On November 15, 2024, BofA Securities Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $3 to $0.50.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Dec 10 ’24 when Colvin Richard A bought 2,824 shares for $0.45 per share.
Obenshain Andrew bought 971 shares of BLUE for $437 on Dec 10 ’24. On Sep 30 ’24, another insider, Klima Thomas J, who serves as the insider of the company, sold 1,006 shares for $0.53 each. As a result, the insider received 529 and left with 170,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BLUE now has a Market Capitalization of 87305584 and an Enterprise Value of 321886080. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.53. Its current Enterprise Value per Revenue stands at 5.863 whereas that against EBITDA is -1.065.
Stock Price History:
Over the past 52 weeks, BLUE has reached a high of $3.58, while it has fallen to a 52-week low of $0.29. The 50-Day Moving Average of the stock is -6.18%, while the 200-Day Moving Average is calculated to be -51.24%.
Shares Statistics:
According to the various share statistics, BLUE traded on average about 7.65M shares per day over the past 3-months and 16243200 shares per day over the past 10 days. A total of 193.92M shares are outstanding, with a floating share count of 192.72M. Insiders hold about 0.89% of the company’s shares, while institutions hold 34.11% stake in the company. Shares short for BLUE as of 1730332800 were 47705814 with a Short Ratio of 5.70, compared to 1727654400 on 48991273. Therefore, it implies a Short% of Shares Outstanding of 47705814 and a Short% of Float of 26.66.
